HEADER HYDROLASE/HYDROLASE INHIBITOR 03-MAR-14 2MLM TITLE SOLUTION STRUCTURE OF SORTASE A FROM S. AUREUS IN COMPLEX WITH TITLE 2 BENZO[D]ISOTHIAZOL-3-ONE BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SORTASE FAMILY PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1323661; SOURCE 4 GENE: CA347_2602; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET23A KEYWDS HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.JAUDZEMS,D.ZHULENKOVS,A.LEONCHIKS REVDAT 3 27-JUN-18 2MLM 1 REMARK SSBOND REVDAT 2 17-DEC-14 2MLM 1 JRNL REVDAT 1 19-NOV-14 2MLM 0 JRNL AUTH D.ZHULENKOVS,Z.RUDEVICA,K.JAUDZEMS,M.TURKS,A.LEONCHIKS JRNL TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF JRNL TITL 2 IRREVERSIBLE BENZISOTHIAZOLINONE-BASED INHIBITORS AGAINST JRNL TITL 3 STAPHYLOCOCCUS AUREUS SORTASE A TRANSPEPTIDASE. JRNL REF BIOORG.MED.CHEM. V. 22 5988 2014 JRNL REFN ISSN 0968-0896 JRNL PMID 25282649 JRNL DOI 10.1016/J.BMC.2014.09.011 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2, CYANA 2.1 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MLM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000103762. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.6 MM [U-100% 13C; U-100% 15N] REMARK 210 SORTASE A-1, 2.4 MM N-(ADAMANTAN-1-YL)-2-(3-OXO-2,3-DIHYDRO-1,2- REMARK 210 BENZOTHIAZOL-2-YL)-ACETAMIDE-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % REMARK 210 [U-100% 2H] DMSO-4, 20 MM [U-100% 2H] SODIUM ACETATE-5, 50 MM REMARK 210 SODIUM CHLORIDE-6, 10 MM CALCIUM CHLORIDE-7, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 CBCA(CO)NH; 3D 1H-15N NOESY; 3D REMARK 210 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 13C NOESY AROMATIC; 3D (F1)-15N, REMARK 210 13C-FILTERED 1H-13C NOESY REMARK 210 ALIPHATIC; 2D (F1,F2)-13C,15N- REMARK 210 FILTERED NOESY; 2D (F1,F2)-13C, REMARK 210 15N-FILTERED TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1, TOPSPIN 3.2, VNMRJ REMARK 210 2.1B, CARA 1.9.0, UNIO 2.0.2 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HB2 ASP A 102 HD3 LYS A 138 1.31 REMARK 500 HH21 ARG A 139 O2 2W7 A 201 1.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 2 -164.70 -122.68 REMARK 500 1 ILE A 65 -90.17 -129.28 REMARK 500 1 THR A 106 -59.49 74.30 REMARK 500 1 TYR A 129 103.11 -171.82 REMARK 500 2 LYS A 26 81.60 -161.95 REMARK 500 2 LEU A 75 21.77 -76.09 REMARK 500 2 PRO A 105 -158.81 -104.13 REMARK 500 2 ASP A 128 93.62 55.76 REMARK 500 2 GLU A 137 -75.48 -81.57 REMARK 500 3 PRO A 5 107.10 -49.84 REMARK 500 3 LYS A 9 34.08 -89.51 REMARK 500 3 ALA A 34 98.46 -63.80 REMARK 500 3 ASP A 118 -157.59 -104.89 REMARK 500 3 LYS A 119 95.39 -68.11 REMARK 500 4 GLN A 2 -96.84 -123.49 REMARK 500 4 ALA A 3 -178.48 -171.00 REMARK 500 4 LYS A 26 78.03 -152.52 REMARK 500 4 ALA A 34 109.93 -57.95 REMARK 500 4 ARG A 41 -64.86 -95.00 REMARK 500 4 GLU A 48 39.12 -95.28 REMARK 500 4 SER A 82 -158.36 -86.26 REMARK 500 4 ASP A 112 -164.15 -107.87 REMARK 500 4 ASP A 118 -166.72 -165.45 REMARK 500 4 THR A 125 52.25 -105.61 REMARK 500 4 TYR A 129 114.07 -168.13 REMARK 500 4 LYS A 138 130.54 -176.86 REMARK 500 4 ARG A 139 -82.30 -161.28 REMARK 500 5 GLN A 6 -166.03 -121.13 REMARK 500 5 LEU A 39 20.65 -78.69 REMARK 500 5 THR A 73 -46.11 -133.30 REMARK 500 5 MET A 97 48.29 -78.87 REMARK 500 5 ASP A 128 128.17 76.22 REMARK 500 5 GLU A 137 -76.23 -118.73 REMARK 500 6 ILE A 7 109.84 -59.90 REMARK 500 6 ASP A 54 -167.48 -77.90 REMARK 500 6 THR A 63 -86.10 -94.26 REMARK 500 6 ILE A 65 -72.71 -127.49 REMARK 500 6 MET A 97 46.88 -81.67 REMARK 500 6 PRO A 105 46.23 -76.58 REMARK 500 6 ASP A 118 -164.99 175.19 REMARK 500 6 GLU A 137 -66.09 -95.76 REMARK 500 7 GLN A 55 41.53 -102.18 REMARK 500 7 ASN A 56 126.69 -171.94 REMARK 500 7 ASP A 118 -178.83 -175.23 REMARK 500 7 LYS A 132 -79.77 -73.28 REMARK 500 7 GLU A 137 -87.29 -71.77 REMARK 500 8 ARG A 41 -43.64 -137.11 REMARK 500 8 ALA A 46 -79.93 -83.96 REMARK 500 8 GLU A 47 77.32 -160.00 REMARK 500 8 GLU A 50 -150.02 -156.97 REMARK 500 REMARK 500 THIS ENTRY HAS 165 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2W7 A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19826 RELATED DB: BMRB DBREF 2MLM A 2 148 UNP R9YTM5 R9YTM5_STAAU 60 206 SEQADV 2MLM MET A 1 UNP R9YTM5 EXPRESSION TAG SEQRES 1 A 148 MET GLN ALA LYS PRO GLN ILE PRO LYS ASP LYS SER LYS SEQRES 2 A 148 VAL ALA GLY TYR ILE GLU ILE PRO ASP ALA ASP ILE LYS SEQRES 3 A 148 GLU PRO VAL TYR PRO GLY PRO ALA THR PRO GLU GLN LEU SEQRES 4 A 148 ASN ARG GLY VAL SER PHE ALA GLU GLU ASN GLU SER LEU SEQRES 5 A 148 ASP ASP GLN ASN ILE SER ILE ALA GLY HIS THR PHE ILE SEQRES 6 A 148 ASP ARG PRO ASN TYR GLN PHE THR ASN LEU LYS ALA ALA SEQRES 7 A 148 LYS LYS GLY SER MET VAL TYR PHE LYS VAL GLY ASN GLU SEQRES 8 A 148 THR ARG LYS TYR LYS MET THR SER ILE ARG ASP VAL LYS SEQRES 9 A 148 PRO THR ASP VAL GLU VAL LEU ASP GLU GLN LYS GLY LYS SEQRES 10 A 148 ASP LYS GLN LEU THR LEU ILE THR CYS ASP ASP TYR ASN SEQRES 11 A 148 GLU LYS THR GLY VAL TRP GLU LYS ARG LYS ILE PHE VAL SEQRES 12 A 148 ALA THR GLU VAL LYS HET 2W7 A 201 47 HETNAM 2W7 N-{2-OXO-2-[(3S,5S,7S)-TRICYCLO[3.3.1.1~3,7~]DEC-1- HETNAM 2 2W7 YLAMINO]ETHYL}-2-SULFANYLBENZAMIDE FORMUL 2 2W7 C19 H24 N2 O2 S HELIX 1 1 PRO A 21 ASP A 24 5 4 HELIX 2 2 GLU A 37 ARG A 41 5 5 SHEET 1 A 8 ILE A 25 VAL A 29 0 SHEET 2 A 8 GLY A 16 ILE A 20 -1 N GLY A 16 O VAL A 29 SHEET 3 A 8 MET A 83 VAL A 88 -1 O TYR A 85 N GLU A 19 SHEET 4 A 8 GLU A 91 VAL A 103 -1 O TYR A 95 N VAL A 84 SHEET 5 A 8 ARG A 139 GLU A 146 -1 O VAL A 143 N SER A 99 SHEET 6 A 8 GLN A 120 CYS A 126 -1 N LEU A 123 O PHE A 142 SHEET 7 A 8 ASN A 56 HIS A 62 1 N GLY A 61 O ILE A 124 SHEET 8 A 8 SER A 44 PHE A 45 -1 N SER A 44 O ALA A 60 LINK SG CYS A 126 S2 2W7 A 201 1555 1555 2.03 SITE 1 AC1 6 VAL A 108 GLU A 113 ILE A 124 CYS A 126 SITE 2 AC1 6 TRP A 136 ARG A 139 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1